Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,259 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

NCT04790253

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations: Medical University of Graz - Radio-oncology Graz, Austria

Institut Jules Bordet Anderlecht, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

AZ Groeninge Kortrijk - Campus Kennedylaan Kortrijk, Belgium

View all 41 locations

View Trial Details

Recruiting

Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

NCT05997719

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, China

View Trial Details

Recruiting

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

NCT05550961

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Recruiting

SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations

NCT06080776

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression

NCT05777278

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)

NCT05724004

Conditions: ALK Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Recruiting

Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer

NCT05241028

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jun Feng Liu Shijiazhuang, Hebei, China

View Trial Details

Recruiting

Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC

NCT04631770

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ethics review board of Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

NCT06041776

Conditions: Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Peking University International Hospital Beijing, China

Jiangsu Cancer Hospital Nanjing, China

Shanghai chest hospital Shanghai, China

View Trial Details

Recruiting

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse

NCT05732974

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Julien MAZIERES Toulouse, France

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions